While these studies show the efficacy of these drugs, its still not clear whether the weight lost through GLP-1 drugs consists of fat, muscle or both
GLP-1 receptor activation in the hypothalamus reduces hunger signals
In the D-allulose phase, participants experienced a dose-dependent reduction of plasma glucose at 30 minutes compared with placebo.* Specifically, the 7.5 gram and 10 gram doses led to a significantly lower glucose response.* In addition, at 30 minutes, D-allulose was associated with a trend towards lower insulin levels compared with placebo, which was significant with the 10 gram dose.* As a zero-calorie sweetener, D-allulose is a good choice for patients on a weight management program.* It has demonstrated impressive supportive results in this area, including a study of 121 Korean subjects aged 20 to 40 years with a body mass index 23 kg/m
Castejon et al., 2021), oral and intravenous GSH (Cazzola et al., 2021), and sublingual and/or oral liposomal GSH administration (Schmitt et al., 2015
In this sense, L-glutamine acts as a precursor
